Close this search box.


Anna Hung, PharmD, PhD, MS

Junior Investigative Intensive Program Alumna

Durham, North Carolina

Assistant Professor in Population Health Sciences,

Core Faculty, Duke-Margolis Center for Health Policy

Research Health Scientist, Center of Innovation to Accelerate Discovery and Practice Transformation

Duke University School of Medicine

When we asked Dr. Hung what her favorite aspect of USDeN was, she couldn’t think of a single thing—rather, she offered three: “There are too many aspects that I think are unique and great… so I’m sorry, but I can’t pick one! A few that come top of mind are: (1) the interdisciplinary nature (e.g., various health care professionals, different types of researchers), (2) commitment to the importance of patient and stakeholder involvement, and (3) international involvement.”

Moreover, Dr. Hung believes that being part of this network “has allowed me to develop new research collaborations and fund work that I can use as pilot data for larger grant proposals. USDeN’s Junior Investigator Intensive Program and Pilot Award in particular were very helpful in growing these research collaborations and studies, and I would highly recommend.” 

In fact, a collaborative commentary she led and that was published in the American Journal of Geriatric Medicine titled, “Value Assessment of Deprescribing Interventions: Suggestions for Improvement,” arose from an USDeN annual meeting workshop with Junior Investigator Intensive Program alumni. “Being part of this team of diverse, interdisciplinary investigators across many institutions both in the U.S. and outside was a great learning experience,” said Dr. Hung; and she continued, “Each of us brought a different perspective, and it was fun and engaging to bounce ideas off each other and work towards a commentary related to how to assess the value of deprescribing interventions.”  The thoughtful and insightful commentary reflects the input of nine experienced deprescribing researchers affiliated with 16 institutions spanning the globe.

“I think many of us deprescribing researchers recognize that the overuse of medications is a widespread, significant problem,” says Dr. Hung.

The recognition that we still have a long way to go in terms of achieving optimal medication management, and that it is very complicated, motivated her to become an investigator into deprescribing research.  We look forward to future collaborations with her to this purpose.

Recent Research

Value Assessment of Deprescribing Interventions: Suggestions for Improvement


Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.